Jingwu Zhang Zang
Directeur/Bestuurslid bij HH&L ACQUISITION CO.
Vermogen: 7 M $ op 30-04-2024
Actieve functies van Jingwu Zhang Zang
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
HH&L ACQUISITION CO. | Directeur/Bestuurslid | 04-02-2021 | - |
Independent Dir/Board Member | 04-02-2021 | - | |
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | Oprichter | 01-06-2016 | - |
Voorzitter | 24-08-2016 | - | |
Algemeen Directeur | 24-08-2016 | - |
Loopbaan van Jingwu Zhang Zang
Eerdere bekende functies van Jingwu Zhang Zang
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
I-MAB | Directeur/Bestuurslid | 01-10-2019 | 01-03-2021 |
Algemeen Directeur | 01-01-2022 | 30-09-2022 | |
Voorzitter | 01-03-2021 | 10-02-2024 | |
Oprichter | 30-06-2016 | 10-02-2024 | |
SIMCERE PHARMACEUTICAL GROUP LIMITED | President | 01-09-2013 | 01-04-2016 |
BioSciKin Co., Ltd.
BioSciKin Co., Ltd. Pharmaceuticals: MajorHealth Technology BioSciKin Co., Ltd. develops drugs and medical products. The private company is based in Nanjing, China. | Hoofd Techniek/Wetenschap/O&O | 01-09-2013 | 01-04-2016 |
President | 01-09-2013 | 01-04-2016 | |
Glaxosmithkline China Ltd. | Hoofd Techniek/Wetenschap/O&O | 01-04-2007 | 01-06-2013 |
Shanghai Jiao Tong University School of Medicine | Corporate Officer/Principal | 01-06-2002 | 01-04-2007 |
Institut Pasteur de Shanghai
Institut Pasteur de Shanghai Miscellaneous Commercial ServicesCommercial Services Institut Pasteur de Shanghai operates as a non-profit life sciences organization. The private company is based in Shanghai, China. | Directeur/Bestuurslid | 01-10-2004 | 01-09-2006 |
The Institute of Health Sciences | Directeur/Bestuurslid | - | - |
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░ ░░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Opleiding van Jingwu Zhang Zang
Shanghai Jiao Tong University | Doctorate Degree |
Vrije Universiteit Brussel | Doctorate Degree |
Statistieken
Internationaal
China | 8 |
Verenigde Staten | 4 |
Hongkong | 3 |
Operationeel
Director/Board Member | 4 |
Corporate Officer/Principal | 3 |
President | 2 |
Sectoraal
Health Technology | 6 |
Consumer Services | 5 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
SIMCERE PHARMACEUTICAL GROUP LIMITED | Health Technology |
I-MAB | Health Technology |
Bedrijven in privébezit | 7 |
---|---|
Opexa Pharmaceuticals, Inc. | Health Technology |
Institut Pasteur de Shanghai
Institut Pasteur de Shanghai Miscellaneous Commercial ServicesCommercial Services Institut Pasteur de Shanghai operates as a non-profit life sciences organization. The private company is based in Shanghai, China. | Commercial Services |
Glaxosmithkline China Ltd. | |
The Institute of Health Sciences | |
BioSciKin Co., Ltd.
BioSciKin Co., Ltd. Pharmaceuticals: MajorHealth Technology BioSciKin Co., Ltd. develops drugs and medical products. The private company is based in Nanjing, China. | Health Technology |
I-MAB Biopharma Co., Ltd.
I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China. | Health Technology |
HH&L Acquisition Co.
HH&L Acquisition Co. Financial ConglomeratesFinance HH&L Acquisition Co. is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on September 4, 2020 and is headquartered in Hong Kong. | Finance |
- Beurs
- Insiders
- Jingwu Zhang Zang
- Ervaring